Studies have revealed that miR-130b promotes tumor aggressiveness by suppressing PPARγ but promotes VEGF-A expression and epithelial to mesenchymal transition (EMT) in hepatocellular [18] and colorectal cancer [5]. Here, VEGFA is linked to neoplasm.